Company / Named in our posts
Disc.
Follow DiscDisc is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients with hematologic disorders. It is building a portfolio of potential first-in-class therapeutic candidates that affect fundamental pathways of red blood cell biology.[1]
01Deal
Deals on Carrywatch
Every deal that names Disc, and its role in each.
Gemini Therapeutics, Inc. / Disc
Gemini Therapeutics and Disc Medicine agree to merge
See deal detailsDeal Web
Disc and 0 firms it shares a posted deal with, and the path to any other firm.
News
Loading headlines.
Sources
As of 24 Oct 2026.
- 01Form 8-K Current Report
U.S. Securities and Exchange Commission · Researched 24 Oct 2026
Deal posts naming Disc:
- P01